Fulacimstat

N/A

Report date: 2024/10/10 20:00:04
NME

Base Information

Drug NameFulacimstat
Drug Alias NameBAY-1142524
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChymase inhibitors
TargetsChymase
Therapy Area/IndicationsMyocardial InfarctionHeart FailureDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaSweden +[10
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsMyocardial InfarctionDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A